Vladimir E. Popov

Vladimir E. Popov

Auto-generated profile, based on publicly available information

Vladimir E. Popov

Moscow Regional Research and Clinical Institute (“MONIKI”)

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 July 2018 in Oncopediatrics
Verified
Journal Article
Open access
PDF file
LOLyudmila V. Olkhova
Lyudmila V. Olkhova
VPVladimir E. Popov
Vladimir E. Popov
Background.Currently, vascular access is one of the most important aspects in specific and accompanying treatment of cancer patients regardless of their age and sex. Partially implanted venous catheters previously described by Hickman were widely applied all over the world. The introduction of completely implanted venous port-systems revolutionized health care delivery and improved the quality of life in patients with oncological diseases. A fully implanted venous port consists of a silicone catheter which distal tip is connected to a port tank implanted subcutaneously. Such a design allows providing safe and multiple adequate vascular accesses regardless of the patient’s clinical state.Case Report.We present a clinical case of a 10-year-old patient diagnosed with medulloblastoma of the cerebellopontine angle and the left cerebellar hemisphere. The case described spontaneous detachment of an implanted venous port catheter and its migration to the venous heart in a patient who underwent chemotherapy by venous access provided through implantation of the venous port.Conclusion.Our clinical case demonstrated a rare and potentially extremely dangerous noninfectious complication associated with the use of venous port-systems. Implanted systems require washing 1–2 times per month with heparinized solutions or solutions containing taurolidine when they are not used. Periodic chest radiographs can reveal integrity alterations of the system. Any implanted system should be removed when it is not used, or it should be monitored on a regular basis.

1 January 2022 in Burdenko's Journal of Neurosurgery
Verified
Journal Article
Closed access
VPV.E. Popov
V.E. Popov
RMR.B. Mai
R.B. Mai
Depressed skull fractures (ping-pong) in the fetus and newborn are associated with birth canal pathology, maternal trauma and birth trauma following instrumental delivery. The authors report a newborn with a depressed skull fracture (ping-pong) who underwent minimally invasive neurosurgical lifting of bone fragment through a burr hole. Strategy and methods of treatment of similar depressed skull fractures were comprehensively discussed. Moreover, the authors proposed a brief algorithm for the use of vacuum systems and various surgical techniques, including follow-up depending on type, cause, size of the fracture and concomitant intracranial lesions.

15 June 2021 in I.P. Pavlov Russian Medical Biological Herald
Verified
Journal Article
Closed access
PDF file
RMRoni B. Mai
Roni B. Mai
VPVladimir E. Popov
Vladimir E. Popov
EOEgor Olegovich Osidak
Egor Olegovich Osidak
SDSergey P. Domogatsky
Sergey P. Domogatsky
ANAleksandr E. Nalivkin
Aleksandr E. Nalivkin
ДПДомогатский Сергей Петрович
Домогатский Сергей Петрович
AIM: This study aimed to summarize the accumulated experience and compare available materials for the plasty of dura mater (DM) defects. The growing number of patients with craniocerebral traumas and an increasing amount of neurological surgeries for tumor processes and congenital malformations resulted in an increased amount of DM defects and associated complications. Despite the development of high-efficiency medical products, the percentage of postsurgical CSF leakage remains high and reaches 32% in case the defect is in infratentorial locations. Suitable substitute materials should be developed for the repair of dural defects because of complications such as pseudomeningocele, postsurgical inflammatory processes, CSF leakage, implant rejection, and cicatrical adhesion. In this article, basic materials, including auto- and allografts, biological substances, and synthetic materials, for the repair of dural defects were reviewed. Their positive and negative properties depending on the kind and location of lesions and on the type of material used were discussed. The main characteristics to be fulfilled by an ideal dura mater substitute were analyzed. Composite materials were considered a promising trend in modern bioengineering. CONCLUSION: An ideal material for the repair of DM defects should have the following properties: plastic, nonimmunogenic, watertight, highly porous, high surface area of fibers, cell growth stimulating, supportive for the survival of cells until they completely integrate with host tissues, conveniently replaceable, and adhesive. No ideal transplant materials can meet all the above demands. Biological, synthetic, and host tissues only supplement one another. Relevant studies have yet to be performed to obtain a more versatile and time and cost effective material that can satisfy all the requirements of modern neurosurgery. The existing results of preclinical studies have demonstrated that composite materials are similar to synthetic materials in terms of the strength and properties of biological tissues for the migration and proliferation of cells. In the future, they may become a promising alternative to biological substitutes.

1 March 2024 in Child's Nervous System
Verified
Journal Article
Closed access
PDF file
RMRoni Mai
Roni Mai
VPVladimir Popov
Vladimir Popov
EMEkaterina Mishina
Ekaterina Mishina
EOEgor Olegovich Osidak
Egor Olegovich Osidak

10 November 2025 in Child's Nervous System
Verified
Journal Article
Open access
PDF file
RMRoni Mai
Roni Mai
DRDmitriy Reshchikov
Dmitriy Reshchikov
VPVladimir Popov
Vladimir Popov
SGSergey Gorelikov
Sergey Gorelikov
EZEKATERINA ZAKHAROVA
EKATERINA ZAKHAROVA
SMSvetlana Mikhaylova
Svetlana Mikhaylova
Purpose: We present two clinical cases of frameless, neuronavigated gene therapy with eladocagene exuparvovec for aromatic L-amino acid decarboxylase (AADC) deficiency in pediatric patients, detailing the targeted bilateral microdose delivery of viral vectors into the putamen and highlighting the feasibility and challenges of this approach in managing a rare neurometabolic disorder. Methods: Two patients with a confirmed diagnosis of AADCD underwent frameless stereotactic gene therapy. High-resolution 3 T MRI-guided trajectories were planned for the targeted bilateral putaminal infusion of 0.32 ml of eladocagene exuparvovec (AAV2-hAADC). The agent was delivered via a SmartFlow Neuro Ventricular Cannula in a “Z-pattern,” retracting the cannula 2 mm every 9 min to achieve controlled microdosing. Results: Accurate frameless drug delivery was achieved in a shorter time than frame-based approaches, with no intraoperative or postoperative complications. One patient showed a small post-ischemic cyst on the 1-month follow-up MRI, without any neurological deficits. Over 2 months, both patients demonstrated reduced oculogyric crises, diminished hyperkinesis, and improved head control, with no significant adverse events. Conclusion: Frameless, neuronavigated gene therapy for AADC deficiency proved both feasible and safe, with early clinical improvements observed in motor function and symptom control. This technique offers a promising alternative to frame-based methods and expands treatment options for this rare neurometabolic disorder.

21 May 2021 in Pediatric Hematology/Oncology and Immunopathology
Verified
Journal Article
Open access
PDF file
LOL. V. Olkhova
L. V. Olkhova
OZO. G. Zheludkova
O. G. Zheludkova
LZL. S. Zubarovskaya
L. S. Zubarovskaya
ASA. Yu. Smirnova
A. Yu. Smirnova
YDYu. V. Dinikina
Yu. V. Dinikina
ТСТ. Ю. Скворцова
Т. Ю. Скворцова
Atypical teratoid/rhabdoid tumor (AT/RT) of the central nervous system (CNS) is an aggressive malignant tumor that is mainly found in younger children and is associated with poor prognosis. Our objectives: to present the results of treatment of children with CNS AT/RT under 3 years of age and assess the impact of various prognostic factors on patient survival. The study was approved by the Independent Ethics Committee and the Scientific Council of the N.I. Pirogov Russian National Research Medical University of Ministry of Healthcare of the Russian Federation. The study included 106 patients with CNS AT/RT aged 0–3 years who had been treated and monitored from 2008 to 2020. The median age was 16 (9; 23) months. All the patients underwent primary tumor resection with subsequent chemotherapy according to various protocols. At the time of the analysis, 47 patients (44.4%) were alive, 1 patient (0.9%) was lost to follow-up and 58 patients (54.7%) were dead, of whom 52 patients (90%) had died of disease progression and 6 (10%) – of polychemotherapy complications. One patient developed shunt-related intraabdominal metastasis within 10 months of the diagnosis. The 1-year progression-free survival (PFS) was 0.50; the 2-year PFS was 0.29; the 5-year PFS – 0.27. The median PFS was 12 months. The 1-year overall survival (OS) was 0.72; the 2-year OS was 0.53; the 5-year OS – 0.40. The median OS was 27 months. An analysis of patients with CNS AT/RT under 3 years of age showed that PFS was statistically significantly higher in: children aged 12 months; children with totally resected tumours; children who had received polychemotherapy in accordance with the ATRT-2006 protocol that included radiotherapy and regional administration of a triplet of chemotherapeutic agents. The OS in patients with CNS AT/RT aged 3 years was statistically significantly higher in: children aged 12 months; children who had been treated with radiation therapy; patients who had received cytosar/etoposide intrathecally/intraventricularly; patients who had undergone high-dose chemotherapy with subsequent autologous hematopoietic stem cell transplantation. A multivariate analysis revealed that PFS was influenced by age, tumor location, extent of resection and exposure to radiation therapy, regional chemotherapy or high-dose chemotherapy with autologous hematopoietic stem cell transplantation, while OS was affected by age and exposure to radiation therapy.